Dr Xiaomin Zhong
Contact information
Research groups
Xiaomin Zhong
BSc, MSc, PhD
Health Data Epidemiologist
Xiaomin (Billy) Zhong is a dedicated health data scientist and epidemiologist with a robust academic foundation and a demonstrated history of applied research. He joined the Applied Health Research Unit (AHRU) as a Health Data Epidemiologist in 2023 after completing a PhD in Health Informatics and an MSc in Health Data Science from the University of Manchester, complemented by a BSc from Peking University, China.
His doctoral research delved into the antibiotic treatment pathways for common infections in English primary care and the identification of predictors for adverse outcomes amidst the COVID-19 pandemic, leveraging the OpenSAFELY platform.
During his PhD from 2021 to 2023, Xiaomin spearheaded significant studies on antibiotic prescription trends, publishing six peer-reviewed papers. His collaborative efforts with the OpenSAFELY team from the Bennett Institute for Applied Data Science at Oxford University entailed the meticulous analysis of over 24 million patient-level electronic health records using advanced data analysis tools and statistical models.
Xiaomin's commitment to healthcare innovation continued into 2023 with a critical investigation into non-COVID-related sepsis during the pandemic. This research, in partnership with the UK Health Security Agency, aims to illuminate clinical and health inequality risk factors under the "Core20PLUS5" approach, enhancing the collective understanding of sepsis in unprecedented times.
Recent publications
-
Rapid systematic review on risks and outcomes of sepsis: the influence of risk factors associated with health inequalities
Journal article
Bladon S. et al, (2024), International Journal for Equity in Health, 23
-
Trends in incidence of pneumothorax in England before, during and after the COVID-19 pandemic (2017-2023): a population-based observational study.
Journal article
Zhong X. et al, (2024), Lancet Reg Health Eur, 44
-
Risk of emergency hospital admission related to adverse events after antibiotic treatment in adults with a common infection: impact of COVID-19 and derivation and validation of risk prediction models.
Journal article
Zhong X. et al, (2024), BMC Med, 22
-
Exploring Prior Antibiotic Exposure Characteristics for COVID-19 Hospital Admission Patients: OpenSAFELY
Journal article
Yang Y-T. et al, (2024), Antibiotics, 13, 566 - 566
-
Sepsis and case fatality rates and associations with deprivation, ethnicity, and clinical characteristics: population-based case–control study with linked primary care and hospital data in England
Journal article
van Staa TP. et al, (2024), Infection